More Info

General Info
Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. The company has collaborated with pharmaceutical partners to develop and market product candidates. Rigel has product development programs in inflammatory/autoimmune diseases, such as rheumatoid arthritis, thrombocytopenia, asthma and allergy, as well as in cancer. Its lead product candidate, R788, completed Phase I clinical trials for the treatment of rheumatoid arthritis, in 2005.
Extra Phones

Phone: (650) 624-1100

Phone: (650) 615-9068

Phone: (650) 877-0646

Phone: (650) 741-6317

Fax: (650) 624-1101

TollFree: (800) 983-1329

Location
Gateway Commons
AKA

Rigel Pharmaceuticals, Inc

TLC Biopharmaceutical

Elan Pharmaceuticals

Categories

Reviews

Hi there!
Be the first to review!
What do you rate this business?First-classBetter than mostAbout what I expectedNot the worst...Disappointing
Click to Rate

Details

Phone: (617) 498-3300

Address: 611 Gateway Blvd, South San Francisco, CA 94080

Website: https://www.rigel.com

People Also Viewed